VOYA Investment Management’s AVEO Pharmaceuticals, Inc. AVEO Stock Holding History

VOYA Investment Management’s Portfolio AVEO Stock Details AVEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-10,342	Closed	-$76K	–	2978
2021 Q1	$76K	Hold	10,342	–	–	﹤0.01%	2707
2020 Q4	$60K	Buy	+10,342	New	+$59.2K	﹤0.01%	2639
2019 Q2	–	Sell	-4,259	Closed	-$35K	–	2645
2019 Q1	$35K	Hold	4,259	–	–	﹤0.01%	2523
2018 Q4	$68K	Buy	4,259 +477	+13%	+$10.5K	﹤0.01%	2456
2018 Q3	$125K	Hold	3,782	–	–	﹤0.01%	2460
2018 Q2	$85K	Buy	+3,782	New	+$89.7K	﹤0.01%	2544

Other funds holding AVEO

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

JGC

J. Goldman & Co New York $3.44B AUM 33.8% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

VOYA Investment Management's AVEO Position: Q2 2021 in Review

VOYA Investment Management sold out of AVEO Pharmaceuticals, Inc. (AVEO) in Q2 2021, closing a stake of 10,342 shares — an estimated $76K sold.

VOYA Investment Management first reported a position in AVEO in Q2 2018 and held it in 6 quarters. The position peaked at $125K in Q3 2018. 63 funds tracked by Wall St. Rank hold AVEO as of Q2 2021.

VOYA Investment Management reported no remaining AVEO Pharmaceuticals, Inc. position as of Q2 2021 after selling out during the quarter.
VOYA Investment Management sold 10,342 AVEO Pharmaceuticals, Inc. shares in Q2 2021, an estimated $76K.
VOYA Investment Management first reported a position in AVEO Pharmaceuticals, Inc. in Q2 2018 and held it in 6 quarters.
VOYA Investment Management's AVEO Pharmaceuticals, Inc. position peaked at $125K in Q3 2018.
63 funds tracked by Wall St. Rank held AVEO Pharmaceuticals, Inc. as of Q2 2021.

Based on VOYA Investment Management's 13F filing for Q2 2021, filed 16 Aug 2021.